PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26171219-1	2015	Recent findings indicate that fingolimod, the first oral drug approved for the treatment of multiple sclerosis (MS), acts as a direct inhibitor of histone deacetylases (HDACs) and enhances the production of brain-derived neurotrophic factor (BDNF) in the CNS.	Fingolimod Hydrochloride	30-40	brain derived neurotrophic factor	Mus musculus	207-240	
26171219-1	2015	Recent findings indicate that fingolimod, the first oral drug approved for the treatment of multiple sclerosis (MS), acts as a direct inhibitor of histone deacetylases (HDACs) and enhances the production of brain-derived neurotrophic factor (BDNF) in the CNS.	Fingolimod Hydrochloride	30-40	brain derived neurotrophic factor	Mus musculus	242-246